Supernus Pharma and Indivior have signed an all-stock merger agreement that would establish a new company, focused on central ...

Novartis paid out $195 million in 2020 to settle a criminal claim brought by the federal government – at the time, the ...

An experimental Novo Nordisk drug for cardiovascular diseases, the IL-6 inhibitor ziltivekimab, has failed the phase 3 ZEUS ...

There are rumours that a pharma 'mega-merger' – between AstraZeneca and Bristol Myers Squibb – is in the offing, ending several years without this type of deal. A report in the Financial Times ...

Agentic AI represents a bridge between predictive, generative, and autonomous systems. Building that bridge to last requires ...

A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health information with third-party companies, including Google and ...

Ireland is attracting major investment from the largest pharma companies in the world. Ben Hargreaves finds out how the country has become one of the most significant locations in Europe for ...

A US judge has ordered that Novo Nordisk must face some allegations in court that it defrauded investors by making misleading ...

Norgine's CEO Janneke van der Kamp has said other portfolio-boosting deals could be on the way. Netherlands-based pharma group Norgine has expanded its rare disease portfolio with the acquisition of ...

Scribe Therapeutics has become the latest biotech to list on the Nasdaq in the US, raising more than $155 million to advance ...

Life sciences equipment and consumable manufacturer Repligen has reached a deal to buy cell therapy specialist BioLife ...

According to a letter (PDF) signed by US Senators Elizabeth Warren (D-Mass), Angela Alsobrooks (D-Md), Richard Blumenthal ...